Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Accumulated Depreciation & Amortization (2018 - 2025)

Viemed Healthcare's Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $28.6 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 12.79% year-over-year to $28.6 million; the TTM value through Dec 2025 reached $28.6 million, up 12.79%, while the annual FY2025 figure was $28.6 million, 12.79% up from the prior year.
  • Accumulated Depreciation & Amortization reached $28.6 million in Q4 2025 per VMD's latest filing, up from $21.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $28.6 million in Q4 2025 to a low of -$67.8 million in Q3 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is -$4.4 million, with a median of $12.2 million recorded in 2021.
  • The largest YoY upside for Accumulated Depreciation & Amortization was 187.42% in 2021 against a maximum downside of 1996.49% in 2021.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at -$60.3 million in 2021, then surged by 125.93% to $15.6 million in 2022, then surged by 39.87% to $21.9 million in 2023, then rose by 16.04% to $25.4 million in 2024, then increased by 12.79% to $28.6 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Accumulated Depreciation & Amortization are $28.6 million (Q4 2025), $21.0 million (Q3 2025), and $13.5 million (Q2 2025).